Allspring Global Investments Holdings, LLC Ironwood Pharmaceuticals Inc Transaction History

Allspring Global Investments Holdings, LLC

$62.2 Billion
Q1 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 79,361 shares of IRWD stock, worth $515,052. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,361

Previous 79,361 -0.0%

Holding current value

$515,052

Previous $691,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$8.32 - $15.45 $255,798 - $475,010	30,745 Added 63.24%	79,361 $691,000
Q4 2023 Jan 25, 2024	BUY	$8.79 - $11.51 $369,979 - $484,467	42,091 Added 645.07%	48,616 $556,000
Q3 2023 Oct 27, 2023	BUY	$8.25 - $11.35 $53,831 - $74,058	6,525 New	6,525 $62,000
Q2 2023 Jul 18, 2023	SELL	$10.1 - $11.6 $1.43 Million - $1.64 Million	-141,772 Reduced 51.8%	131,926 $1.4 Million
Q1 2023 Apr 13, 2023	BUY	$10.37 - $12.56 $986,301 - $1.19 Million	95,111 Added 53.26%	273,698 $2.88 Million

Q4 2022 Jan 23, 2023	SELL	$9.9 - $12.43 $1.13 Million - $1.42 Million	-114,617 Reduced 39.09%	178,587 $0
Q3 2022 Oct 26, 2022	BUY	$10.14 - $12.38 $116,447 - $142,171	11,484 Added 4.08%	293,204 $3.04 Million
Q2 2022 Jul 25, 2022	SELL	$11.05 - $12.72 $7.32 Million - $8.42 Million	-662,218 Reduced 70.15%	281,720 $3.25 Million
Q1 2022 May 02, 2022	BUY	$10.61 - $12.88 $20,052 - $24,343	1,890 Added 0.2%	943,938 $11.9 Million
Q4 2021 Jan 28, 2022	BUY	$10.86 - $13.95 $10.2 Million - $13.1 Million	942,048 New	942,048 $11 Million

Others Institutions Holding IRWD

# of Institutions

296

Shares Held

170M

Call Options Held

27.1M

Put Options Held

2.28M

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $994M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Ironwood Pharmaceuticals Inc Transaction History